Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Jun. 30, 2021
Jun. 30, 2020
Revenues:        
Collaboration revenue $ 554,000 $ 1,015,000
Revenues 554,000 1,015,000
Operating expenses:        
Research and development 2,747,000 1,976,000 4,324,000 3,259,000
General and administrative 1,081,000 2,028,000 2,242,000 3,167,000
Total operating expenses 3,828,000 4,004,000 6,566,000 6,426,000
Loss from operations (3,828,000) (3,450,000) (6,566,000) (5,411,000)
Other income (expense):        
Interest expense, net (2,000) (2,000) (3,000) (4,000)
Change in fair value of derivative liabilities 9,000 (43,000) 10,000 (70,000)
Total other income (expense), net 7,000 (45,000) 7,000 (74,000)
Net loss $ (3,821,000) $ (3,495,000) $ (6,559,000) $ (5,485,000)
Net loss per common share, basic and diluted $ (0.04) $ (0.07) $ (0.08) $ (0.12)
Weighted average number of common shares outstanding, basic and diluted 87,069 52,141 79,116 46,930